24 related articles for article (PubMed ID: 23645746)
1. Experimental evidence of Migfilin as a new therapeutic target of hepatocellular carcinoma metastasis.
Gkretsi V; Bogdanos DP
Exp Cell Res; 2015 Jun; 334(2):219-27. PubMed ID: 25773778
[TBL] [Abstract][Full Text] [Related]
2. PRC2 targeting is a therapeutic strategy for EZ score defined high-risk multiple myeloma patients and overcome resistance to IMiDs.
Herviou L; Kassambara A; Boireau S; Robert N; Requirand G; Müller-Tidow C; Vincent L; Seckinger A; Goldschmidt H; Cartron G; Hose D; Cavalli G; Moreaux J
Clin Epigenetics; 2018 Oct; 10(1):121. PubMed ID: 30285865
[TBL] [Abstract][Full Text] [Related]
3. circFBLIM1 act as a ceRNA to promote hepatocellular cancer progression by sponging miR-346.
Bai N; Peng E; Qiu X; Lyu N; Zhang Z; Tao Y; Li X; Wang Z
J Exp Clin Cancer Res; 2018 Jul; 37(1):172. PubMed ID: 30053867
[TBL] [Abstract][Full Text] [Related]
4. Cell Adhesion and Matrix Stiffness: Coordinating Cancer Cell Invasion and Metastasis.
Gkretsi V; Stylianopoulos T
Front Oncol; 2018; 8():145. PubMed ID: 29780748
[TBL] [Abstract][Full Text] [Related]
5. Expression of migfilin is increased in esophageal cancer and represses the Akt-β-catenin activation.
He H; Ding F; Li S; Chen H; Liu Z
Am J Cancer Res; 2014; 4(3):270-8. PubMed ID: 24959381
[TBL] [Abstract][Full Text] [Related]
6. Om.breast cancer in very young women aged 25 year-old or below in the center of Tunisia and review of the literature.
Ben Abdelkrim S; Fathallah K; Rouatbi R; Ayachi M; Hmissa S; Mokni M
Pathol Oncol Res; 2015 Jul; 21(3):553-61. PubMed ID: 25962349
[TBL] [Abstract][Full Text] [Related]
7. Migfilin: Cell Adhesion Effect and Comorbidities.
Duan B; Qin Z; Gu X; Li Y
Onco Targets Ther; 2022; 15():411-422. PubMed ID: 35469339
[TBL] [Abstract][Full Text] [Related]
8. Tumor-suppressive microRNA-34a inhibits breast cancer cell migration and invasion via targeting oncogenic TPD52.
Li G; Yao L; Zhang J; Li X; Dang S; Zeng K; Zhou Y; Gao F
Tumour Biol; 2016 Jun; 37(6):7481-91. PubMed ID: 26678891
[TBL] [Abstract][Full Text] [Related]
9. Ras suppressor-1 promotes apoptosis in breast cancer cells by inhibiting PINCH-1 and activating p53-upregulated-modulator of apoptosis (PUMA); verification from metastatic breast cancer human samples.
Giotopoulou N; Valiakou V; Papanikolaou V; Dubos S; Athanassiou E; Tsezou A; Zacharia LC; Gkretsi V
Clin Exp Metastasis; 2015 Mar; 32(3):255-65. PubMed ID: 25647720
[TBL] [Abstract][Full Text] [Related]
10. Expression of underglycosylated MUC1 antigen in cancerous and adjacent normal breast tissues.
Ghosh SK; Pantazopoulos P; Medarova Z; Moore A
Clin Breast Cancer; 2013 Apr; 13(2):109-18. PubMed ID: 23122537
[TBL] [Abstract][Full Text] [Related]
11. A novel biomarker C6orf106 promotes the malignant progression of breast cancer.
Jiang G; Zhang X; Zhang Y; Wang L; Fan C; Xu H; Miao Y; Wang E
Tumour Biol; 2015 Sep; 36(10):7881-9. PubMed ID: 25953261
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of CXCL12 mRNA expression by promoter hypermethylation and its association with metastatic progression in human breast carcinomas.
Zhou W; Jiang Z; Liu N; Xu F; Wen P; Liu Y; Zhong W; Song X; Chang X; Zhang X; Wei G; Yu J
J Cancer Res Clin Oncol; 2009 Jan; 135(1):91-102. PubMed ID: 18670789
[TBL] [Abstract][Full Text] [Related]
13. Mitogen-inducible Gene-2 (MIG2) and migfilin expression is reduced in samples of human breast cancer.
Gkretsi V; Papanikolaou V; Zacharia LC; Athanassiou E; Wu C; Tsezou A
Anticancer Res; 2013 May; 33(5):1977-81. PubMed ID: 23645746
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
